Ultra-high b-value DWI in rectal cancer: image quality assessment and regional lymph node prediction based on radiomics
- PMID: 38992110
- DOI: 10.1007/s00330-024-10958-3
Ultra-high b-value DWI in rectal cancer: image quality assessment and regional lymph node prediction based on radiomics
Abstract
Objectives: This study aims to evaluate image quality and regional lymph node metastasis (LNM) in patients with rectal cancer (RC) on multi-b-value diffusion-weighted imaging (DWI).
Methods: This retrospective study included 199 patients with RC who had undergone multi-b-value DWI. Subjective (five-point Likert scale) and objective assessments of quality images were performed on DWIb1000, DWIb2000, and DWIb3000. Patients were randomly divided into a training (n = 140) or validation cohort (n = 59). Radiomics features were extracted within the whole volume tumor on ADC maps (b = 0, 1000 s/mm2), DWIb1000, DWIb2000, and DWIb3000, respectively. Five prediction models based on selected features were developed using logistic regression analysis. The performance of radiomics models was evaluated with a receiver operating characteristic curve, calibration, and decision curve analysis (DCA).
Results: The mean signal intensity of the tumor (SItumor), signal-to-noise ratio (SNR), and artifact and anatomic differentiability score gradually were decreased as the b-value increased. However, the contrast-to-noise (CNR) on DWIb2000 was superior to those of DWIb1000 and DWIb3000 (4.58 ± 0.86, 3.82 ± 0.77, 4.18 ± 0.84, p < 0.001, respectively). The overall image quality score of DWIb2000 was higher than that of DWIb3000 (p < 0.001) and showed no significant difference between DWIb1000 and DWIb2000 (p = 0.059). The area under curve (AUC) value of the radiomics model based on DWIb2000 (0.728) was higher than conventional ADC maps (0.690), DWIb1000 (0.699), and DWIb3000 (0.707), but inferior to multi-b-value DWI (0.739) in predicting LNM.
Conclusion: DWIb2000 provides better lesion conspicuity and LNM prediction than DWIb1000 and DWIb3000 in RC.
Clinical relevance statement: DWIb2000 offers satisfactory visualization of lesions. Radiomics features based on DWIb2000 can be applied for preoperatively predicting regional lymph node metastasis in rectal cancer, thereby benefiting the stratified treatment strategy.
Key points: Lymph node staging is required to determine the best treatment plan for rectal cancer. DWIb2000 provides superior contrast-to-noise ratio and lesion conspicuity and its derived radiomics best predict lymph node metastasis. DWIb2000 may be recommended as the optimal b-value in rectal MRI protocol.
Keywords: Diffusion magnetic resonance imaging; Lymphatic metastasis; Machine learning; Rectal neoplasms.
© 2024. The Author(s), under exclusive licence to European Society of Radiology.
Conflict of interest statement
Compliance with ethical standards. Guarantor: The scientific guarantor of this publication is Jinsong Zhang. Conflict of interest: J.R. is an employee of GE Healthcare. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. Statistics and biometry: No complex statistical methods were necessary for this paper. Informed consent: Informed consent was obtained from all patients acquired for multi-b-value DWI examination in this study, while the informed consent of clinical data collection was waived by the Institutional Review Board due to the retrospective nature of this study. Ethical approval: Institutional Review Board approval was obtained. Study subjects or cohorts overlap: There were 230 patients overlapping with the previous published study. Some published studies have been previously reported in European Radiology ( https://doi.org/10.1007/s00330-022-09159-7 ) and Cancer Image ( https://doi.org/10.1186/s40644-023-00582-7 ), while this study focused on Image quality analysis and lymph node metastasis evaluation based on radiomics features derived from DWIb1000, DWIb2000, DWIb3000 in rectal cancer. Methodology: Retrospective Observational Performed at one institution
Similar articles
-
Research progress in multimodal radiomics of rectal cancer tumors and peritumoral regions in MRI.Abdom Radiol (NY). 2025 May 31. doi: 10.1007/s00261-025-04965-1. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40448847 Review.
-
MRI radiomic study on prediction of nonenlarged lymph node metastasis of rectal cancer: reduced field-of-view versus conventional DWI.Eur Radiol Exp. 2025 Mar 22;9(1):34. doi: 10.1186/s41747-025-00575-0. Eur Radiol Exp. 2025. PMID: 40120024 Free PMC article.
-
A Nomogram of Combining IVIM-DWI and MRI Radiomics From the Primary Lesion of Rectal Adenocarcinoma to Assess Nonenlarged Lymph Node Metastasis Preoperatively.J Magn Reson Imaging. 2022 Sep;56(3):658-667. doi: 10.1002/jmri.28068. Epub 2022 Jan 28. J Magn Reson Imaging. 2022. PMID: 35090079
-
Clinical development of MRI-based multi-sequence multi-regional radiomics model to predict lymph node metastasis in rectal cancer.Abdom Radiol (NY). 2024 Jun;49(6):1805-1815. doi: 10.1007/s00261-024-04204-z. Epub 2024 Mar 10. Abdom Radiol (NY). 2024. PMID: 38462557
-
Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis.BMC Cancer. 2021 Sep 26;21(1):1058. doi: 10.1186/s12885-021-08773-w. BMC Cancer. 2021. PMID: 34565338 Free PMC article.
Cited by
-
Diffusion-weighted imaging in rectal cancer MRI from theory to practice.Abdom Radiol (NY). 2025 Jul 11. doi: 10.1007/s00261-025-05102-8. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40643654 Review.
-
Research progress in multimodal radiomics of rectal cancer tumors and peritumoral regions in MRI.Abdom Radiol (NY). 2025 May 31. doi: 10.1007/s00261-025-04965-1. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40448847 Review.
-
Predicting Surgical Difficulty in Rectal Cancer Surgery: A Systematic Review of Artificial Intelligence Models Applied to Pre-Operative MRI.Cancers (Basel). 2025 Feb 26;17(5):812. doi: 10.3390/cancers17050812. Cancers (Basel). 2025. PMID: 40075659 Free PMC article. Review.
-
MRI radiomic study on prediction of nonenlarged lymph node metastasis of rectal cancer: reduced field-of-view versus conventional DWI.Eur Radiol Exp. 2025 Mar 22;9(1):34. doi: 10.1186/s41747-025-00575-0. Eur Radiol Exp. 2025. PMID: 40120024 Free PMC article.
-
Robustness of radiomics within photon-counting detector CT: impact of acquisition and reconstruction factors.Eur Radiol. 2025 Aug;35(8):4661-4673. doi: 10.1007/s00330-025-11374-x. Epub 2025 Jan 31. Eur Radiol. 2025. PMID: 39890616 Free PMC article.
References
-
- Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7–33 - PubMed
-
- Hashiguchi Y, Muro K, Saito Y et al (2020) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25:1–42 - PubMed
-
- Benson AB, Venook AP, Al-Hawary MM et al (2022) Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20:1139–1167 - PubMed
-
- Gao Y, Li J, Ma X et al (2019) The value of four imaging modalities in diagnosing lymph node involvement in rectal cancer: an overview and adjusted indirect comparison. Clin Exp Med 19:225–234 - PubMed
-
- Beets-Tan RGH, Lambregts DMJ, Maas M et al (2018) Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28:1465–1475 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources